LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced its results for the first quarter ended March 31, 2012. Net sales of $143.1 million represent an increase of 3% over the first quarter last year. Strategic product sales, which exclude trailing revenues from the divested vascular business, grew 4% on a reported basis and 5% on a constant currency basis. Net income was $12 million, or $0.63 per diluted share compared to a loss of $2.00 in the prior year. Adjusted net income was $13.2 million, or $0.69 per diluted share compared to $0.59 in the prior year, increasing 17% from the first quarter of the prior year.
